Platelet-type von Willebrand disease
Miller, J.L.
Thrombosis and Haemostasis 75(6): 865-869
1996
ISSN/ISBN: 0340-6245 PMID: 8822577 Document Number: 457087
Document emailed within 1 workday
Related Documents
Inbal, A.; Kornbrot, N.; Harrison, P.; Randi, A.M.; Sadler, J.E. 1993: Effect of type IIB von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein Ib binding--studies with recombinant von Willebrand factor Thrombosis and Haemostasis 70(6): 1058-1062Francesconi, M.A.; Deana, R.; Girolami, A.; Pontara, E.; Casonato, A. 1993: Platelet aggregation induced by plasma from type IIB von Willebrand's disease patients is associated with an increase in cytosolic Ca2+ concentration Thrombosis and Haemostasis 70(4): 697-701
Mazurier, C.; Meyer, D. 1996: Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 76(2): 270-274
Piao, Y.C.; Lavergne, J.M.; Boyer-Neumann, C.; Schandelong, A.; Alessi, M.C.; Meyer, D. 1993: Arg578Gln mutations in the von Willebrand factor gene in three unrelated cases of type IIB von Willebrand disease Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 4(5): 787-789
Rastegar-Lari, G.; Ajzenberg, N.; Ribba, A.S.; Vereycken-Holler, V.; Legendre, P.; Villoutreix, B.; Meyer, D.; Baruch, D. 2001: Defect of heparin binding in plasma and recombinant von Willebrand factor with type 2 von Willebrand disease mutations Thrombosis and Haemostasis 86(6): 1459-1465
Escolar, G.; Carretero, M.; Magallón, M.; Quintana, M.; Arnau, C.; Castillo, R.; Aznar-Salatti, J. 1998: von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease Haematologica 83(11): 1009-1014
Van Vliet, H.H.D.M.; Kappers-Klunne, M.C.; Leebeek, F.W.G.; Michiels, J.J. 2008: PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2 Thrombosis and Haemostasis 100(3): 462-468
Pareti, F.I.; Cattaneo, M.; Carpinelli, L.; Zighetti, M.L.; Bressi, C.; Mannucci, P.M.; Ruggeri, Z.M. 1996: Evaluation of the abnormal platelet function in von Willebrand disease by the blood filtration test Thrombosis and Haemostasis 76(3): 460-468
Nordmann, A. 1998: Mild von type i von Willebrand disease Praxis 87(21): 747-748
Habart, D. 2003: Von Willebrand disease type 2N (Normandy) Vnitrni Lekarstvi 49(4): 253-255
Kauhanen, P.; Beer, J.H.; Lassila, R. 1997: Defective interaction between von Willebrand factor and platelet glycoprotein Ib--a familial study of peripheral arterial occlusive disease Thrombosis and Haemostasis 77(5): 849-855
Pfueller, S.L.; Howard, M.A.; White, J.G.; Menon, C.; Berry, E.W. 1987: Shortening of bleeding time by 1-deamino-8-arginine vasopressin (DDAVP) in the absence of platelet von Willebrand factor in Gray platelet syndrome Thrombosis and Haemostasis 58(4): 1060-1063
Inocêncio, G.; Braga, A.; Azevedo, S.; Buchner, G. 2013: Management of von Willebrand disease type 3 during pregnancy - 2 cases reports European Review for Medical and Pharmacological Sciences 17(21): 2857-2859
Coughlan, T.C.; Blagg, J.L.; Abulola, M.; Daly, M.E.; Hampton, K.K.; Makris, M.; Peake, I.R.; Goodeve, A.C. 1999: Null alleles are not a common cause of type 1 von Willebrand disease in the British population Thrombosis and Haemostasis 82(4): 1373-1375
Gadisseur, A.P.; Vrelust, I.; Vangenechten, I.; Schneppenheim, R.; Van der Planken, M. 2007: Identification of a novel candidate splice site mutation (0874 + 1G > A) in a type 3 von Willebrand disease patient Thrombosis and Haemostasis 98(2): 464-466
Castaman, G.; Eikenboom, J.C.; Bertina, R.M.; Rodeghiero, F. 1999: Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation Thrombosis and Haemostasis 82(3): 1065-1070
Silva, C.D.; Geraldes, F.; Silva, I.S. 2013: Levonorgestrel intrauterine system as a treatment option for severe menorrhagia in adolescent with type IIi von Willebrand disease BMJ Case Reports
Hilbert, L.; Federici, A.B.; Baronciani, L.; Dallagiovanna, S.; Mazurier, C. 2004: A new candidate mutation, G1629R, in a patient with type 2A von Willebrand's disease: basic mechanisms and clinical implications Haematologica 89(9): 1128-1133
Fukui, H.; Okuda, T.; Takase, T.; Mikami, S.; Yoshioka, A.; Fujimura, Y.; Yoshioka, K. 1978: Two cases of atypical von Willebrand's disease with inhibitory effect on von Willebrand factor Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 41(5): 897-907
Fukui, H.; Yoshioka, A.; Mikami, S.; Takase, T.; Fujimura, Y.; Takahashi, Y.; Nishino, M.; Iwagaki, K. 1979: Pathophysiology of von Willebrand's disease: Qualitative and quantitative analysis of von Willebrand protein Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 42(6): 839-850